164 related articles for article (PubMed ID: 1650194)
1. 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymphocytes.
Balzarini J; Lee CK; Schols D; De Clercq E
Biochem Biophys Res Commun; 1991 Jul; 178(2):563-9. PubMed ID: 1650194
[TBL] [Abstract][Full Text] [Related]
2. Depletion of GTP pool is not the predominant mechanism by which ribavirin exerts its antiviral effect on Lassa virus.
Ölschläger S; Neyts J; Günther S
Antiviral Res; 2011 Aug; 91(2):89-93. PubMed ID: 21616094
[TBL] [Abstract][Full Text] [Related]
3. Eicar (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide). A novel potent inhibitor of inosinate dehydrogenase activity and guanylate biosynthesis.
Balzarini J; Karlsson A; Wang L; Bohman C; Horská K; Votruba I; Fridland A; Van Aerschot A; Herdewijn P; De Clercq E
J Biol Chem; 1993 Nov; 268(33):24591-8. PubMed ID: 7901217
[TBL] [Abstract][Full Text] [Related]
4. Antiviral efficacy of EICAR against canine distemper virus (CDV) in vitro.
Dal Pozzo F; Galligioni V; Vaccari F; Gallina L; Battilani M; Scagliarini A
Res Vet Sci; 2010 Apr; 88(2):339-44. PubMed ID: 19781726
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of the potentiating effect of ribavirin on the activity of 2',3'-dideoxyinosine against human immunodeficiency virus.
Balzarini J; Lee CK; Herdewijn P; De Clercq E
J Biol Chem; 1991 Nov; 266(32):21509-14. PubMed ID: 1939181
[TBL] [Abstract][Full Text] [Related]
6. Mechanism-based design of inosine 5-monophosphate dehydrogenase inhibitors: synthesis and biological activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and its derivatives.
Minakawa N; Matsuda A
Curr Med Chem; 1999 Jul; 6(7):615-28. PubMed ID: 10390604
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses.
Shigeta S; Mori S; Baba M; Ito M; Honzumi K; Nakamura K; Oshitani H; Numazaki Y; Matsuda A; Obara T
Antimicrob Agents Chemother; 1992 Feb; 36(2):435-9. PubMed ID: 1605607
[TBL] [Abstract][Full Text] [Related]
8. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
Leyssen P; Balzarini J; De Clercq E; Neyts J
J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
[TBL] [Abstract][Full Text] [Related]
9. 5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2',3'-dideoxyinosine.
Gong YF; Srinivas RV; Fridland A
Mol Pharmacol; 1993 Jul; 44(1):30-6. PubMed ID: 8341276
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of infectious pancreatic necrosis virus (IPNV) replication.
Jashés M; González M; López-Lastra M; De Clercq E; Sandino A
Antiviral Res; 1996 Mar; 29(2-3):309-12. PubMed ID: 8739609
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activities of 5-ethynyl-1-beta-D-ribofuranosylimidazole-4- carboxamide and related compounds.
De Clercq E; Cools M; Balzarini J; Snoeck R; Andrei G; Hosoya M; Shigeta S; Ueda T; Minakawa N; Matsuda A
Antimicrob Agents Chemother; 1991 Apr; 35(4):679-84. PubMed ID: 2069373
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication.
Jashés M; Mlynarz G; De Clercq E; Sandino AM
Antiviral Res; 2000 Jan; 45(1):9-17. PubMed ID: 10774586
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of pyrimidine metabolism in myeloid leukemia cells by triazole and pyrazole nucleosides.
Matsumoto SS; Fujitaki JM; Nord LD; Willis RC; Lee VM; Sharma BS; Sanghvi YS; Kini GD; Revankar GR; Robins RK
Biochem Pharmacol; 1990 Feb; 39(3):455-62. PubMed ID: 1968339
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
[TBL] [Abstract][Full Text] [Related]
15. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
Hartman NR; Ahluwalia GS; Cooney DA; Mitsuya H; Kageyama S; Fridland A; Broder S; Johns DG
Mol Pharmacol; 1991 Jul; 40(1):118-24. PubMed ID: 1677450
[TBL] [Abstract][Full Text] [Related]
16. Selective guanosine phosphate deficiency in hepatoma cells induced by inhibitors of IMP dehydrogenase.
Kaiser WA; Herrmann B; Keppler DO
Hoppe Seylers Z Physiol Chem; 1980 Oct; 361(10):1503-10. PubMed ID: 6108911
[TBL] [Abstract][Full Text] [Related]
17. Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.
Balzarini J; De Clercq E
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):785-90. PubMed ID: 1359876
[TBL] [Abstract][Full Text] [Related]
18. Potentiating effect of (2-[2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methyl]-phenyl]ethenyl) -phosphonic acid (MDL 74,428), a potent inhibitor of purine nucleoside phosphorylase, on the antiretroviral activities of 2',3'-dideoxyinosine combined with ribavirin in mice.
Weibel M; Balzarini J; Bernhardt A; Mamont P
Biochem Pharmacol; 1994 Jul; 48(2):245-52. PubMed ID: 8053921
[TBL] [Abstract][Full Text] [Related]
19. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication.
Leyssen P; De Clercq E; Neyts J
Mol Pharmacol; 2006 Apr; 69(4):1461-7. PubMed ID: 16421290
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of EICAR (5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide), a potent inhibitor of inosinate dehydrogenase.
Balzarini J; Stet L; Matsuda A; Wiebe L; Knauss E; De Clercq E
Adv Exp Med Biol; 1998; 431():723-8. PubMed ID: 9598159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]